英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

befool    
vt. 愚弄,欺骗

愚弄,欺骗

befool
v 1: make a fool or dupe of [synonym: {fool}, {gull}, {befool}]
2: fool or hoax; "The immigrant was duped because he trusted
everyone"; "You can't fool me!" [synonym: {gull}, {dupe},
{slang}, {befool}, {cod}, {fool}, {put on}, {take in}, {put
one over}, {put one across}]


请选择你想看的字典辞典：
单词字典翻译
befool查看　befool　在百度字典中的解释百度英翻中〔查看〕
befool查看　befool　在Google字典中的解释Google英翻中〔查看〕
befool查看　befool　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Short-term vs Conventional Glucocorticoid Therapy in Acute . . .
    Objective To investigate whether a short-term (5 days) systemic glucocorticoid treatment in patients with COPD exacerbation is noninferior to conventional (14 days) treatment in clinical outcome and whether it decreases the exposure to steroids
  • REDUCE - The Bottom Line
    In patients presenting to the emergency department with acute exacerbations of COPD, 5-day treatment with systemic glucocorticoids was non-inferior to 14-day treatment with regard to re-exacerbation within 6 months of follow-up but significantly reduced glucocorticoid exposure
  • REDUCE - Wiki Journal Club
    All patients received antibiotics, inhaled steroids, inhaled tiotropium, and inhaled short-acting beta-agonists The shorter course was non-inferior to the longer course in rates of re-exacerbations at 180 days Additionally, there was no difference in the use of open-label glucocorticoids
  • Short term glucocorticoid therapy in acute exacerbations of chronic . . .
    In this trial, we aimed to demonstrate non-inferiority of 5-days vs 14-days of systemic glucocorticoids with respect to COPD exacerbation Methods: Patients admitted to hospital with AECOPD were randomized to receive 40mg of prednisone-equivalent daily for either 5 or 14 days in a placebo-controlled fashion
  • Approach to discontinuing systemic glucocorticoid therapy in . . . - UpToDate
    When providers anticipate stopping systemic glucocorticoid therapy, the approach to discontinuation should be guided by the patient's risk of developing glucocorticoid-induced adrenal insufficiency (AI) as well as a flare of the underlying disease
  • Protocol 05PRT 17 - The Lancet
    Our aim is to study whether, in AECOPD, short-term (5 days) systemic glucocorticoid treatment will not result in worse clinical outcome than conventional (14 days) treatment, but will decrease the exposure to steroids and reduce their side-effects
  • Reduce Trial - criticalthinkinginmedicine. com
    At the time of the trial, there was no standard steroid treatment for COPD and patients were exposed to long treatments or tapers
  • Short-term vs conventional glucocorticoid therapy in acute . . .
    Objective: To investigate whether a short-term (5 days) systemic glucocorticoid treatment in patients with COPD exacerbation is noninferior to conventional (14 days) treatment in clinical outcome and whether it decreases the exposure to steroids
  • Effect of different corticosteroid regimes for hospitalised patients . . .
    We pooled individual patient data from the two available multicentre randomised trials on corticosteroid-sparing regimens for AECOPD: the REDUCE (n = 314) and CORTICO-COP (n = 318) trials
  • Short versus conventional term glucocorticoid therapy in acute . . .
    The aim of this trial is to demonstrate non-inferiority of a five-day compared to a 14-day course of systemic glucocorticoids with respect to COPD outcome, thereby significantly reducing steroid exposure and side effects in patients with COPD exacerbations





中文字典-英文字典  2005-2009